TUNA was found to be increased in human breast cancer tissues, and in vitro experiments on human breast cancer cell lines suggest that TUNA promotes oncogenic activity through the expression of SOX2 and promotion of epithelial-to-mesenchymal transition (Li et al., 2017). The gene discussed is SOX2; the disease is breast carcinoma.